Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Routine HPA-screening in Pregnancy to Prevent FNAIT: Assessing Disease Burden and Optimising Risk Group Selection

NCT04067375 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04067375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Routine HPA-screening in Pregnancy to Prevent FNAIT: Assessing Disease Burden and Optimising Risk Group Selection
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
April 1, 2020
Enrollment
3,660 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal and neonatal alloimmune thrombocytopenia